Transave's Merger

Transave raised a round of funding on December 02, 2010. Investors include Insmed.

Transave is a biotechnology company whose mission is to improve the treatment of serious lung diseases through the development of novel site-specific liposomal drug products. The company's liposomal …

Articles about Transave's Merger: